News & Updates

What is the most preferred first-line agent for paediatric alopecia areata?
What is the most preferred first-line agent for paediatric alopecia areata?
25 May 2022 byStephen Padilla

In the treatment of paediatric alopecia areata (AA), an autoimmune, nonscarring hair loss disorder with a variable disease course and significant psychosocial impact, the most preferred first-line agent is topical corticosteroids, followed by contact immunotherapy, according to a study.

What is the most preferred first-line agent for paediatric alopecia areata?
25 May 2022
Prenatal Zika delays neurodevelopment in kids
Prenatal Zika delays neurodevelopment in kids
25 May 2022

Infants of mothers with Zika virus infection suffer from various neurodevelopmental sequelae during childhood, particularly in terms of language, a new study reveals.

Prenatal Zika delays neurodevelopment in kids
25 May 2022
Isolated systolic hypertension tied to increased LV mass index, aortic stiffness in adolescents
Isolated systolic hypertension tied to increased LV mass index, aortic stiffness in adolescents
21 May 2022

Adolescents with isolated systolic hypertension (ISH), including the spurious hypertension (sHTN) subtype, show more noticeable markers of cardiac end-organ damage, higher aortic stiffness, and stroke volume than those with white-coat hypertension (WCH), a study has shown.

Isolated systolic hypertension tied to increased LV mass index, aortic stiffness in adolescents
21 May 2022
Male sex, obesity among risk factors for severe COVID-19 in children
Male sex, obesity among risk factors for severe COVID-19 in children
20 May 2022
Short-course IV antibiotics should be considered for nonbacteraemic UTI in babies
Short-course IV antibiotics should be considered for nonbacteraemic UTI in babies
18 May 2022

In the treatment of young infants with nonbacteraemic urinary tract infection (UTI), administering intravenous (IV) antibiotics for less than 48 hours appears to work well in the absence of meningitis, with low rates of treatment failure and serious complications, according to a study.

Short-course IV antibiotics should be considered for nonbacteraemic UTI in babies
18 May 2022